Back to Search Start Over

Baxter breaks off biopharma solutions segment in $4.25B private equity deal.

Authors :
Park, Andrea
Source :
FierceBiotech; 5/8/2023, pN.PAG-N.PAG, 1p
Publication Year :
2023

Abstract

Baxter is saying bye-bye, biopharma. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
PRIVATE equity
MERGERS & acquisitions

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
163631184

Tools

Authors Abstract Subjects Details